Literature DB >> 10749126

Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors.

D L Cheo1, L B Meira, D K Burns, A M Reis, T Issac, E C Friedberg.   

Abstract

Mutations in nucleotide excision repair (NER) genes in humans result in the UV-induced skin cancer-prone disease xeroderma pigmentosum (XP). Mouse models that mimic XP have provided an informative experimental system with which to study DNA repair, as well as the molecular pathology of UV radiation-induced skin cancer. We reported previously that mice defective in the Xpc gene (Xpc-/-) are highly predisposed to UVB radiation-induced skin cancer and that the appearance of skin cancer is more rapid in Xpc Trp53 double mutants. Extended studies now demonstrate an increased predisposition to UVB radiation-induced skin cancers in Xpc heterozygous mice compared with normal mice. We also show that Xpc Trp53 double heterozygous mutants are more predisposed to skin cancer than Trp53 single heterozygous mice. No mutations were detected in the cDNA of the remaining Xpc allele, suggesting that haploinsufficiency of the Xpc gene may be operating and is a risk factor for UVB radiation-induced skin cancer in mice. Skin tumors from Xpc-/- mice were exclusively well or moderately well-differentiated squamous cell carcinomas. In Xpc+/+ and Xpc+/- mice, many of the squamous cell carcinomas were less well differentiated. We also documented previously increased predisposition to UV radiation-induced skin cancers in Xpc-/- Apex+/- mice. Here we show the absence of mutations in the cDNA of the remaining Apex allele, a further suggestive indication of haploinsufficiency and its resulting predisposition to skin cancer. The Trp53 and Apex heterozygous conditions altered the skin tumor spectrum to more poorly differentiated forms in all Xpc genotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749126

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Rous-Whipple Award Lecture. Nucleotide excision repair and cancer predisposition: A journey from man to yeast to mice.

Authors:  E C Friedberg
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice.

Authors:  David A Goukassian; Elizabeth Helms; Harry van Steeg; Conny van Oostrom; Jag Bhawan; Barbara A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

Review 3.  Haploinsufficiency in mouse models of DNA repair deficiency: modifiers of penetrance.

Authors:  Diane C Cabelof
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

4.  Microarray analysis of microRNA expression in skin of Xpc⁺/⁻ mice and wild-type mice.

Authors:  B Zhou; H Wu; W Li; W Liu; D Luo
Journal:  Ir J Med Sci       Date:  2010-10-26       Impact factor: 1.568

5.  XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas.

Authors:  Hamid Reza Rezvani; Arianna L Kim; Rodrigue Rossignol; Nsrein Ali; Meaghan Daly; Walid Mahfouf; Nadège Bellance; Alain Taïeb; Hubert de Verneuil; Frédéric Mazurier; David R Bickers
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

6.  The role of XPC: implications in cancer and oxidative DNA damage.

Authors:  Joost P M Melis; Mirjam Luijten; Leon H F Mullenders; Harry van Steeg
Journal:  Mutat Res       Date:  2011-07-07       Impact factor: 2.433

7.  RADIOSENSITIVITY TO HIGH ENERGY IRON IONS IS INFLUENCED BY HETEROZYGOSITY for ATM, RAD9 and BRCA1.

Authors:  G Zhou; L B Smilenov; H B Lieberman; T Ludwig; E J Hall
Journal:  Adv Space Res       Date:  2010-09-01       Impact factor: 2.152

8.  Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis.

Authors:  Fengtao Su; Lubomir B Smilenov; Thomas Ludwig; Libin Zhou; Jiayun Zhu; Guangming Zhou; Eric J Hall
Journal:  Radiat Oncol       Date:  2010-02-22       Impact factor: 3.481

9.  A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

Authors:  Joseph Vijai; Sabine Topka; Danylo Villano; Vignesh Ravichandran; Kara N Maxwell; Ann Maria; Tinu Thomas; Pragna Gaddam; Anne Lincoln; Sarah Kazzaz; Brandon Wenz; Shai Carmi; Kasmintan A Schrader; Steven N Hart; Steve M Lipkin; Susan L Neuhausen; Michael F Walsh; Liying Zhang; Flavio Lejbkowicz; Hedy Rennert; Zsofia K Stadler; Mark Robson; Jeffrey N Weitzel; Susan Domchek; Mark J Daly; Fergus J Couch; Katherine L Nathanson; Larry Norton; Gad Rennert; Kenneth Offit
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

10.  Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.

Authors:  Robert N Rainey; Sum-Yan Ng; Juan Llamas; Gijsbertus T J van der Horst; Neil Segil
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.